BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 34880855)

  • 1. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
    Zhang C; Feng YG; Tam C; Wang N; Feng Y
    Front Immunol; 2021; 12():733171. PubMed ID: 34880855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
    Ng DL; Granados AC; Santos YA; Servellita V; Goldgof GM; Meydan C; Sotomayor-Gonzalez A; Levine AG; Balcerek J; Han LM; Akagi N; Truong K; Neumann NM; Nguyen DN; Bapat SP; Cheng J; Martin CS; Federman S; Foox J; Gopez A; Li T; Chan R; Chu CS; Wabl CA; Gliwa AS; Reyes K; Pan CY; Guevara H; Wadford D; Miller S; Mason CE; Chiu CY
    Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33536218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity.
    MacCann R; Leon AAG; Gonzalez G; Carr MJ; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Doran P; Mallon PW
    Front Immunol; 2023; 14():1166574. PubMed ID: 37261339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference.
    Zhang Y; Wang C; Han M; Ye J; Gao Y; Liu Z; He T; Li T; Xu M; Zhou L; Zou G; Lu M; Zhang Z
    Virol Sin; 2020 Dec; 35(6):758-767. PubMed ID: 32749593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab.
    Pagella F; Lizzio R; Ugolini S; Spinozzi G; Maiorano E; Suppressa P; Sabbà C; Matti E
    Orphanet J Rare Dis; 2020 Dec; 15(1):350. PubMed ID: 33339521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
    Shaath H; Vishnubalaji R; Elkord E; Alajez NM
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.
    Tovo PA; Garazzino S; Daprà V; Pruccoli G; Calvi C; Mignone F; Alliaudi C; Denina M; Scolfaro C; Zoppo M; Licciardi F; Ramenghi U; Galliano I; Bergallo M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by
    Yi F; Hu J; Zhu X; Wang Y; Yu Q; Deng J; Huang X; Ma Y; Xie Y
    Front Cell Infect Microbiol; 2021; 11():716809. PubMed ID: 34490145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
    Xie TA; He ZJ; Liang C; Dong HN; Zhou J; Fan SJ; Guo XG
    Eur J Med Res; 2021 Dec; 26(1):146. PubMed ID: 34920753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal gene expression in response to SARS-CoV-2 is associated with early viral load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    bioRxiv; 2022 Aug; ():. PubMed ID: 36052371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis.
    Maleknia S; Tavassolifar MJ; Mottaghitalab F; Zali MR; Meyfour A
    Mol Med; 2022 Aug; 28(1):86. PubMed ID: 35922752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
    Hoagland DA; Møller R; Uhl SA; Oishi K; Frere J; Golynker I; Horiuchi S; Panis M; Blanco-Melo D; Sachs D; Arkun K; Lim JK; tenOever BR
    Immunity; 2021 Mar; 54(3):557-570.e5. PubMed ID: 33577760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest.
    Potamias G; Gkoublia P; Kanterakis A
    Front Immunol; 2023; 14():1251067. PubMed ID: 38077337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
    Kulasinghe A; Tan CW; Ribeiro Dos Santos Miggiolaro AF; Monkman J; SadeghiRad H; Bhuva DD; Motta Junior JDS; Busatta Vaz de Paula C; Nagashima S; Baena CP; Souza-Fonseca-Guimaraes P; de Noronha L; McCulloch T; Rossi GR; Cooper C; Tang B; Short KR; Davis MJ; Souza-Fonseca-Guimaraes F; Belz GT; O'Byrne K
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.